AstraZeneca opens Texas pharmaceutical plant after $445 million expansion

AstraZeneca announced October 15 that it had reopened its Coppell, Texas medicine factory following a $445 million expansion to double the site’s production of lokelma, a medicine used to treat high levels of potassium in the blood. In a statement, AstraZeneca’s Senior VP in charge of the company’s American supply operation, said the 10-year-old site’s expansion underlines the company’s commitment to patients and the local workforce.

According to a company release, the factory employs 250 people. The opening of the latest, 9,000-square-foot expansion added two new manufacturing lines as well as space for additional lab testing, warehousing and administrative space.

The Coppell plant is part of the company’s push to spend $50 billion on manufacturing R&D and manufacturing, alongside its plans for a new $4.5 billion plant in Virginia.

What people are saying

“Our manufacturing facility in Coppell serves as both a critical pillar in global healthcare and has played an important role in supporting the local workforce over the past 10 years,” said Jim Fox, Senior VP, AstraZenica Americas Supply Operations. “The expansion underscores our commitment to patients and support for Texas’ long-term vision for scientific growth and innovation.”

Manufacturers investing in Texas

Large-scale additive manufacturing company opens new headquarters and facility in Austin, Texas

Caracol's new U.S. headquarters will include an innovation space for developing alongside local manufacturers.

Race Rock expands manufacturing capacity with new Texas facility
This investment will help the company support Texas and the country’s evolving infrastructure landscape.

TMEIC to build PV inverter manufacturing facility in Texas 
The plant will produce 9 GW annually, with future expansion availability based on market demands. 

Investing in American manufacturing in 2025 

This map shows where manufacturers are choosing to invest their resources, whether they are building new production facilities or expanding existing plants.